Andrology & Gynecology: Current ResearchISSN: 2327-4360

Reach Us +1 850 900 2634
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article, Androl Gynecol Curr Res Vol: 2 Issue: 3

Aromatase Inhibitor for Prevention of Ovarian Hyperstimulation Syndrome(OHSS)

Mosammat Rashida Begum*, Mariya Ehsan, Mosammat Shahina Begum, Hosne Ara Beby, and Maruf Siddiqui
Infertility Care and Research Center (ICRC), Dhaka, Bangladesh
Corresponding author : Prof. Mosammat Rashida Begum
Chief Consultant, Infertility Care and Research Center (ICRC), 5/13 Humaun Road, Block “B”, Mohammadpur, Dhaka 1207, Bangladesh
E-mail: [email protected]
Received: March 14, 2014 Accepted: May 13, 2014 Published: May 17, 2014
Citation: Ehsan M, Begum MS, Beby HA, Siddiqui M, Begum MR (2014) Aromatase Inhibitor for Prevention of Ovarian Hyperstimulation Syndrome (OHSS). Androl Gynecol: Curr Res 2:3. doi: 10.4172/2327-4360.1000125

Abstract

Aromatase Inhibitor for Prevention of Ovarian Hyperstimulation Syndrome(OHSS)

Ovarian hyperstimulation syndrome (OHSS) was first described by Muller in 1962. Since then this iatrogenically originated malady has been reported to afflict high numbers of women who are in infertility treatment. The most serious and potentially lethal complication of controlled ovarian hyperstimulation (COH) is a severe form of OHSS. The incidence of OHSS is 5%-10% of all ovarian hyperstimulation for assisted reproduction treatment. It is characterized by ovarian enlargement with multiple follicular development, intravascular volume depletion and haemoconcentration.

Keywords: Aromatase; Inhibitor; Ovarian; Hyperstimulation; Prevention

Track Your Manuscript

Share This Page

Associations